MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 133 filers reported holding MACROGENICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,293 | +67.4% | 11,059 | +56.7% | 0.01% | +100.0% |
| Q4 2022 | $47,366 | +57.9% | 7,059 | -31.4% | 0.00% | 0.0% |
| Q2 2022 | $30,000 | -71.2% | 10,286 | -13.6% | 0.00% | -66.7% |
| Q1 2022 | $104,000 | +57.6% | 11,900 | +188.2% | 0.01% | +80.0% |
| Q4 2021 | $66,000 | +2100.0% | 4,129 | +3490.4% | 0.01% | – |
| Q2 2020 | $3,000 | – | 115 | -13.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 133 | -98.7% | 0.00% | -100.0% |
| Q4 2019 | $109,000 | +45.3% | 10,036 | +186.2% | 0.01% | +120.0% |
| Q3 2018 | $75,000 | +5.6% | 3,507 | +1.0% | 0.01% | 0.0% |
| Q2 2018 | $71,000 | -12.3% | 3,472 | +7.5% | 0.01% | -28.6% |
| Q1 2018 | $81,000 | +32.8% | 3,230 | +56.9% | 0.01% | 0.0% |
| Q3 2016 | $61,000 | +205.0% | 2,058 | +173.3% | 0.01% | +250.0% |
| Q2 2016 | $20,000 | -66.1% | 753 | -61.1% | 0.00% | -80.0% |
| Q4 2015 | $59,000 | -11.9% | 1,936 | +0.3% | 0.01% | -52.4% |
| Q4 2014 | $67,000 | – | 1,930 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |